You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A badge-like exposure device for occupational safety and epidemiological study

    SBC: TF HEALTH CORPORATION            Topic: 113

    Abstract Chemical exposure poses a threat to the safety and health of each of usespecially those who work in certain industriessuch as petroleum extraction and refinery facilitiesmining industryand fertilizer factoriesVarious sensing technologies have been developed over the past decades to address the needbut a low cost and accurate personal exposure device that can track multiple chemical pollut ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  2. A cost-effective robotic platform for on-demand production of flexibly dosed medications in a chewable gummy dosage form

    SBC: Vitae Industries, Inc.            Topic: NICHD

    PROJECT SUMMARYThis project s goal is to develop an innovative cost effective robotic platform for fast on demand pharmacy production of pediatric drugs as individually tailored palatable gummy dosage formsMedication adherence is notoriously low among children due to difficulty swallowing pills and rejection of bad tasting medicationsAlthough some common pediatric drugs have flavored liquid formsp ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  3. A Deep Learning Model to Improve Pathologist Interpretation of Donor Kidney Biopsies

    SBC: NEWVENTUREIQ LLC            Topic: 300

    PROJECT SUMMARY ABSTRACT More people die every year from kidney disease than breast or prostate cancerKidney transplantation is life saving but is limited by a shortage of organ donors and an unacceptably high donor organ discard rateThe decision to use or discard a donor kidney relies heavily on manual quantitation of key microscopic findings by pathologistsA major limitation of this microscopic ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  4. AFFF Disposal

    SBC: Liquid Carbonic L.L.C.            Topic: AF17BT001

    Aqueous Film Forming Foam (AFFF) is the water-based firefighting agent of choice in military and civilian applications.No satisfactory disposal method has been identified.Liquid Carbonic proposes a treatment for AFFF that will also work for other polyfluorinated chemicals (PFCs) and their derivatives.The strength of the C-F bond is the ultimate problem in disposing of PFCs and residues.The very se ...

    STTR Phase I 2018 Department of DefenseAir Force
  5. A High Resolution Radiation Therapy Dosimetry system

    SBC: DOSEIMAGING, LLC            Topic: 399

    DESCRIPTION provided by applicant Modern radiation therapy treatment modalities such as intensity modulated radiation therapy are associated with complex dose distributions and sharp dose gradients Experimental dose validation using multidimensional high spatial resolution dosimeters is mandatory The product to be developed is a novel high resolution dosimetry system that combines reusabil ...

    STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  6. A New Small-Molecule Kinase Inhibitor for Breast Cancer

    SBC: NuPeak Therapeutics, Inc.            Topic: 102

    NuPeak Therapeutics Incis a biotechnology start up companyC corporationdesigned to deliver a first inclass small molecule kinase inhibitorThe present Project is aimed at an inhibitor for treatment of breast cancerwhich remains a leading cause of morbidity and mortality in the U Sdespite current therapeutic approachesIn that contextwe identified a novel typeimmune response that activates mitogen ac ...

    STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  7. A NON-MELT WELDING PROCESS TO REPAIR TITANIUM BLADES OF IBDS

    SBC: ATS-MER, LLC            Topic: AF161118

    ABSTRACT: Integrally bladed disks (IBDs) are extremely expensive componentry used in military turbine engines which receive foreign object damage to which there is not a proven certifiable repair process.Conventional fusion/melt welding processes affects the surrounding blade material with the fused/melted and heat effected material exhibiting reduced mechanical properties and adverse microstructu ...

    SBIR Phase I 2016 Department of DefenseAir Force
  8. A Novel Inhibitor of the Classical Pathway of Complement

    SBC: AnthroBio, Inc.            Topic: NHLBI

    A novel inhibitor of the classical pathway of the complement system Abstract The classical pathway of the complement system is implicated in the pathogenesis of a number of human autoimmune diseasesincluding systemic lupus erythematosusrheumatoid arthritisalloantibody mediated transplant rejection and autoimmune hemolytic anemiaDespite a large body of literature documenting the role of the complem ...

    SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health
  9. A Novel TGF-β Receptor Antagonist to Treat Pulmonary Fibrosis

    SBC: AUXAGEN, INC.            Topic: NHLBI

    DESCRIPTION provided by applicant Pulmonary fibrosis PF including idiopathic PF IPF is a group of progressive incurable lung diseases with high mortality rates PF is characterized by excessive deposition of extracellular matrix proteins in lung parenchyma via TGF dependent pathways Existing therapies only modestly slow the progression and likely only indirectly impact TGF mediated ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
  10. ANTI-PDZ DOMAIN ANTIBODIES ENHANCE THE EFFICACY OF RADIOTHERAPY

    SBC: Medical Guidance Systems LLC            Topic: 395

    Poor prognosis cancers including cancers of the lung and glioblastoma show robust overexpresion of Tax Interacting Protein TIP The proposed research is a novel approach to cancer drug development in which we target this chaperone protein that binds to signal transduction proteins that enhance cell viability following cytotoxic therapy Stress responses in cancer cells are exaggerated over th ...

    SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government